Rebiotix
Rebiotix Inc. has been integrated into Ferring Pharmaceuticals. If you would like to continue to the Ferring U.S. website click on FerringUSA.com below. If you are interested in the donor program, click on the donor program below.
C diff Clinical Study at MNGI Digestive Health, Plymouth, MN
The study drug, RBX2660, is approved by the US Food and Drug Administration (FDA), and marketed in the United States as REBYOTA™ (fecal microbiota, live – jslm) 1 for rectal administration only. Study doctors want to find out if RBX2660 is also effective in preventing CDI recurrence when given by colonoscopy.
C diff Clinical Study at GI Alliance of Illinois – Glenview, IL
The study drug, RBX2660, is approved by the US Food and Drug Administration (FDA), and marketed in the United States as REBYOTA™ (fecal microbiota, live – jslm) 1 for rectal administration only. Study doctors want to find out if RBX2660 is also effective in preventing CDI recurrence when given by colonoscopy.
C diff Clinical Study at Louisiana Research Center, Shreveport, LA
The study drug, RBX2660, is approved by the US Food and Drug Administration (FDA), and marketed in the United States as REBYOTA™ (fecal microbiota, live – jslm) 1 for rectal administration only. Study doctors want to find out if RBX2660 is also effective in preventing CDI recurrence when given by colonoscopy.
Uncategorized Archives - CDI-SCOPE Clinical Trial
The study drug, RBX2660, is approved by the US Food and Drug Administration (FDA), and marketed in the United States as REBYOTA™ (fecal microbiota, live – jslm) 1 for rectal administration only. Study doctors want to find out if RBX2660 is also effective in preventing CDI recurrence when given by colonoscopy.
- [PDF]
www.rebiotix.com
%PDF-1.5 %âãÏÓ 7 0 obj > endobj 41 0 obj >/Filter/FlateDecode/ID[]/Index[7 90]/Info 6 0 R/Length 148/Prev 127295/Root 8 0 R/Size 97/Type/XRef/W[1 3 1]>>stream ...
www.rebiotix.com
PK !ì”_æ Ð+ [Content_Types].xml ¢ ( ÌšÛRÛ0 †ï;Ówðø¶“86=Ð h¯z` úª½I ¶¤J ·¯l'àЄ˜¬4› ÙÞ ?%ò¿kÅ'g U Ý 6\Šqœ Gq "— ÓqüûúÛà8ŽŒe¢`¥ 0Ž `â³Ó·oN® L䢅 Ç3kÕ—$1ù *f†R pg&RW̺¡ž&Šå·l I6 }Lr), ;°µF|zr 6/môõÁ nI”˜ÆÑy{] j 󪎯 ' #n l iNlŽÑPšg1L©’ç̺óÉ (žÍe°œÇÐE6ט Wæ »`K†úÌö ÛãnÔË ...